Gauteng Surgical Backlog Leaves Cancer Patient in Limbo A Gauteng man with aggressive skin cancer faces an eight-month wait for urgent surgery amid a staggering 34,000-strong surgical backlog, highlighting a deepening healthcare crisis. The Gauteng surgical backlog...

Trump’s Tariff Stick Won’t Bring Generic Drug Manufacturing Home Tariffs on generic drugs are unlikely to reshore manufacturing to the US, according to industry giants Sandoz and Teva. **Focus Keywords:** generic drugs, Trump tariffs, pharmaceutical...

Dis-Chem Ramps Up Rewards & Store Expansion Retailer aims to regain lost market share in key categories, following intense promotional activity from competitors and a rapid expansion of rival store footprints. **TAGS: Dis-Chem, Rewards Programme, Market Share,...

Immunotherapy Offers New Hope Against Early-Stage Cancers Immunotherapy drugs like Opdivo, Imfinzi, and Tecentriq are revolutionising cancer treatment, showing significant success in earlier stages of various cancers, including head and neck, gastric, and colon...

Is Investing in Hospitals a Healthy Bet? Remgro executives are bullish on hospital investments, despite a challenging decade for Netcare and Life Healthcare. Focus keywords: hospital investment, Remgro, Mediclinic, Netcare, Life Healthcare, healthcare sector, paid...